Renal Function and Heart Failure Treatment When Is a Loss Really a Gain?

被引:6
作者
Konstam, Marvin A. [1 ,2 ]
机构
[1] Tufts Med Ctr, CardioVasc Ctr, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
RANDOMIZED-TRIAL; DYSFUNCTION; CAPTOPRIL; MORTALITY; ADMISSION; SURVIVAL; LOSARTAN;
D O I
10.1161/CIRCHEARTFAILURE.111.964874
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:677 / 679
页数:3
相关论文
共 20 条
[1]   Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure [J].
Akhter, MW ;
Aronson, D ;
Bitar, F ;
Khan, S ;
Singh, H ;
Singh, RP ;
Burger, AJ ;
Elkayam, U .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (07) :957-+
[2]   Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction [J].
Al-Ahmad, A ;
Rand, WM ;
Manjunath, G ;
Konstam, MA ;
Salem, DN ;
Levey, AS ;
Sarnak, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) :955-962
[3]   Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial [J].
Blair, John E. A. ;
Pang, Peter S. ;
Schrier, Robert W. ;
Metra, Marco ;
Traver, Brian ;
Cook, Thomas ;
Campia, Umberto ;
Ambrosy, Andrew ;
Burnett, John C., Jr. ;
Grinfeld, Liliana ;
Maggioni, Aldo P. ;
Swedberg, Karl ;
Udelson, James E. ;
Zannad, Faiez ;
Konstam, Marvin A. ;
Gheorghiade, Mihai .
EUROPEAN HEART JOURNAL, 2011, 32 (20) :2563-2572
[4]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[5]   A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure [J].
Cohn, JN ;
Tognoni, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1667-1675
[6]   The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction [J].
Dries, DL ;
Exner, DV ;
Domanski, MJ ;
Greenberg, B ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) :681-689
[7]   Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure [J].
Forman, DE ;
Butler, J ;
Wang, YF ;
Abraham, WT ;
O'Connor, CM ;
Gottlieb, SS ;
Loh, E ;
Massie, BM ;
Rich, MW ;
Stevenson, LW ;
Young, JB ;
Krumholz, HM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (01) :61-67
[8]   Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial [J].
Granger, CB ;
McMurray, JJV ;
Yusuf, S ;
Held, P ;
Michelson, EL ;
Olofsson, B ;
Östergren, J ;
Pfeffer, MA ;
Swedberg, K .
LANCET, 2003, 362 (9386) :772-776
[9]   Renal function, neurohormonal activation, and survival in patients with chronic heart failure [J].
Hillege, HL ;
Girbes, ARJ ;
de Kam, PJ ;
Boomsma, F ;
de Zeeuw, D ;
Charlesworth, A ;
Hampton, JR ;
van Veldhuisen, DJ .
CIRCULATION, 2000, 102 (02) :203-+
[10]   Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial [J].
Konstam, Marvin A. ;
Neaton, James D. ;
Dickstein, Kenneth ;
Drexler, Helmut ;
Komajda, Michel ;
Martinez, Felipe A. ;
Riegger, Gunter A. J. ;
Malbecq, William ;
Smith, Ronald D. ;
Guptha, Soneil ;
Poole-Wilson, Philip A. .
LANCET, 2009, 374 (9704) :1840-1848